Spirit of Cricket!! 👏👏👏

Many congratulations to Mohammad Ali, Johanna Olweus group, SCI, ICR Oslounivsykehus for winning the Kolbjørn Brambani Prize at the Oncology Forum meeting today for his work on TCR cell therapy about to come out in Nature Biotech! @Kreftforeningen RADFORSK @OsloCancer K.G. Jebsen Centre for Cancer Immunotherapy

Very excited to receive the Kolbjørn Brambani’s prize at Oncology Forum meeting Oslo. A great boost to take our newly discovered anti-leukemia immunotherapy to clinics ⁦Johanna Olweus⁩. ⁦Oslounivsykehus⁩ ⁦Barnekreftforeningen⁩ ⁦Nola Susan⁩

After a multi-year effort from so many brilliant people involved in this project, I am excited to share our work published today in Nature Biotechnology. Johanna Olweus Eirini Giannakopoulou Oslounivsykehus Universitetet i Oslo nature.com/articles/s4158…

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes go.nature.com/3GiVNzV

Fantastic work by the Johanna Olweus lab out in Nature Biotechnology today reporting TdT as a target in B- and T-ALL and preclinical documentation of two TCRs that are progressing to clinical trials! Many congratulations! StratCell #ACT #advancedcelltherapy nature.com/articles/s4158…

Tusen takk Kjetil Tasken for din støtte, fine ord og for å skape et forskningsmiljø av verdensklasse i våre Institute for Cancer Research

A really impressive piece of work by Johanna Olweus and her team out today Nature Biotechnology T cell mediated targeting of TdT presented in the context of HLA-A2 in T and B cell ALL. nature.com/articles/s4158…

A Nature Biotechnology paper reports that engineered T cells kill leukemic cells with little off-target toxicity. go.nature.com/3DGf1xM

Godspeed James Webb Space Telescope. May you bring back light from the pioneer stars ✨

T-cell immunity rocks post-vaccination… mostly preserved against Omicron even though the antibodies fade.

Three open postdoc positions in the Olweus lab. Join our enthusiastic team for an exciting opportunity to develop the next generation T cell based cancer immunotherapy! 2411.webcruiter.no/Main2/Recruit/…

Myeloperoxidase, a highly oxidizing enzyme, exerts anti-tumor activity in glioma after radiotherapy. This could help optimize host immune response and therapy for this devastating disease. sciencedirect.com/science/articl… MGH Center for Systems Biology James Brink, MD MGH Radiology Chiefs @MGH_RI MGHNeuroRadFellows Institute for Innovation in Imaging

Small but mighty! This is a video of a killer T cell of the immune system destroying a monstrous ovarian cancer cell. I recently captured this data on a spinning disc confocal microscope.

Last leg of travel to the Keystone, CO is finally over. Stavanger-Oslo-Newark-Harrisburg-Charlotte-Denver-Keystone :-) It’s all worth it to finally attend in-person #EmergingCellularTherapies and #KSPrecisionGene22 at Keystone Symposia

Når kreftceller «sulter», finner de nødløsninger for å overleve. Dette kan gi immunforsvaret nye muligheter til å angripe kreften, fant Johanna Olweus, Morten Milek Nielsen og Maarja Laos i en ny studie publisert i tidsskriftet nature. #kreft @Kreftforeningen med.uio.no/klinmed/forskn…

Very proud of Muhammad Ali and Eirini Giannakopoulou, shared first authors of nature.com/articles/s4158… and winners of Oslounivsykehus award for outstanding articles.

Since the late 1970s, ExxonMobil’s own scientists accurately projected and modeled global warming due to fossil fuel burning and produced results that were consistent with independent academic and government climate models, a new #ScienceReview finds. scim.ag/193

Eloquently dissected and penned down: Trust the scientific process, not just the science. And it matters who does science science.org/content/blog-p…

Excited to share our work, which shows that T cells targeting a shared neoantigen eliminate acute myeloid leukemia, including cancer stem cells, in vivo in a disease-relevant model Norges forskningsråd European Research Council (ERC) @OsloCancer @UiO_LifeSci Oslounivsykehus nature.com/articles/s4301…